Generic · Tablet · Updated Nov 11, 2026
Teriflunomide 7 mg tablet price what pharmacies pay, and what you should
Is my price fair?
Check the price you were quoted
Type what the pharmacy asked for teriflunomide 7 mg tablet and see the markup over what they pay.
A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.
Teriflunomide 7 mg price history
What pharmacies pay for 30 tablets, weekly- Now
- $9.13
- 52-week low
- $8.75
- 52-week high
- $19.72
- A year ago
- $16.26
Why the price changed
| Effective | Before | After | Change | Reason |
|---|---|---|---|---|
| Oct 21, 2026 | $0.2919 | $0.3044 | +4.3% | pharmacies' invoice prices changed (survey) |
| Sep 23, 2026 | $0.2917 | $0.2919 | +0.1% | pharmacies' invoice prices changed (survey) |
| Aug 19, 2026 | $0.2970 | $0.2917 | -1.8% | pharmacies' invoice prices changed (survey) |
| Jul 22, 2026 | $0.3198 | $0.2970 | -7.1% | pharmacies' invoice prices changed (survey) |
| Jun 17, 2026 | $0.3261 | $0.3198 | -1.9% | pharmacies' invoice prices changed (survey) |
| May 20, 2026 | $0.4576 | $0.3261 | -28.8% | pharmacies' invoice prices changed (survey) |
| Apr 22, 2026 | $0.5439 | $0.4576 | -15.9% | pharmacies' invoice prices changed (survey) |
| Mar 18, 2026 | $0.6572 | $0.5439 | -17.2% | pharmacies' invoice prices changed (survey) |
Prices per tablet. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.
What people paid for teriflunomide 7 mg tablet
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
7 companies sell teriflunomide 7 mg tablet under 10 package codes (NDCs). Pharmacies pay the same per tablet whichever maker they buy from - the national average is set for the generic as a group.
| Maker | Package codes | Per unit |
|---|---|---|
| Alembic Pharmaceuticals Inc. | 62332-313-30 | $0.3044 |
| Aurobindo Pharma Limited | 59651-054-30 | $0.3044 |
| Biocon Pharma Inc. | 70377-017-11 | $0.3044 |
| Camber Pharmaceuticals, Inc. | 31722-246-30 | $0.3044 |
| Glenmark Pharmaceuticals Inc., USA | 68462-423-30 | $0.3044 |
| Teva Pharmaceuticals, Inc. | 0480-3157-56 | $0.3044 |
| Zydus Pharmaceuticals USA Inc. | 70710-1114-3 | $0.3044 |
All 10 package codes
3 older package codes are still priced but no longer in the current FDA listing.
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
Questions to ask your pharmacist
- "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
- "Is a 90-day supply cheaper per tablet?" Dispensing fees are charged per fill, so fewer fills often cost less.
- "Would 14 mg tablet work for me instead?" Pharmacies pay $0.2234 per tablet for it, against $0.3044 for this one. Only your prescriber can say whether a different strength or form suits you.
- "Do you match other pharmacies or accept discount cards?" Many do, if you ask.
These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.
Other teriflunomide strengths and forms
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 14 mg tablet | $0.2234 | $6.70 / 30 tablets |
Official label & what changed
These highlights do not include all the information needed to use TERIFLUNOMIDE TABLETS safely and effectively. See full prescribing information for TERIFLUNOMIDE TABLETS. TERIFLUNOMIDE tablets, for oral use Initial U.S. Approval: 2012
WARNING: HEPATOTOXICITY and EMBRYOFETAL TOXICITY
• Hepatotoxicity
Clinically significant and potentially life-threatening liver injury, including acute liver failure requiring transplant, has been reported in patients treated with teriflunomide in the postmarketing setting [see Warnings and Precautions (5.1)]. Concomitant use of teriflunomide with other hepatotoxic drugs may increase the risk of severe liver injury.
Obtain transaminase and bilirubin levels within 6 months before initiation of teriflunomide therapy. Monitor ALT levels at least monthly for six months after starting teriflunomide [see Warnings and Precautions (5.1)]. If drug induced liver injury is suspected, discontinue teriflunomide and start an accelerated elimination procedure with cholestyramine or charcoal [see Warnings and Precautions (5.3)]. Teriflunomide is contraindicated in patients with severe hepatic impairment [see Contraindications (4)]. Patients with pre-existing liver disease may be at increased risk of developing elevated serum transaminases when taking teriflunomide.
• Embryofetal Toxicity
Teriflunomide is contraindicated for use in pregnant women and in females of reproductive potential who are not using effective contraception because of the potential for fetal harm. Teratogenicity and embryolethality occurred in animals at plasma teriflunomide exposures lower than that in humans. Exclude pregnancy before the start of treatment with teriflunomide in females of reproductive potential. Advise females of reproductive potential to use effective contraception during teriflunomide treatment and during an accelerated drug elimination procedure after teriflunomide treatment. Stop teriflunomide and use an accelerated drug elimination procedure if the patient becomes pregnant [see Contraindications (4), Warnings and Precautions (5.2, 5.3), Use in Specific Populations (8.1, 8.3), and Clinical Pharmacology (12.3)].
WARNING: HEPATOTOXICITY and EMBRYOFETAL TOXICITY
See full prescribing information for complete boxed warning.
• Hepatotoxicity
Clinically significant and potentially life-threatening liver injury, including acute liver failure requiring transplant, has been reported in patients treated with teriflunomide in the postmarketing setting (5.1). Concomitant use of teriflunomide with other hepatotoxic drugs may increase the risk of severe liver injury. Obtain transaminase and bilirubin levels within 6 months before initiation of teriflunomide and monitor ALT levels at least monthly for six months (5.1). If drug induced liver injury is suspected, discontinue teriflunomide and start accelerated elimination procedure (5.3).
• Embryofetal Toxicity
Teratogenicity and embryolethality occurred in animals administered teriflunomide (5.2, 8.1). Exclude pregnancy prior to initiating teriflunomide therapy (4, 5.2, 8.1, 8.3). Advise use of effective contraception in females of reproductive potential during treatment and during an accelerated drug elimination procedure (4, 5.2, 5.3, 8.1, 8.3). Stop teriflunomide and use an accelerated drug elimination procedure if the patient becomes pregnant (5.2, 5.3, 8.1).
Recent major changes (as listed on the label)
Warnings and Precautions (5.8) 2/2026
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about teriflunomide 7 mg tablet
How much does teriflunomide 7 mg tablet cost without insurance?
Pharmacies pay about $9.13 for 30 tablets ($0.3044 per tablet) as of November 11, 2026. A fair cash price is about $21.00: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $20.50 including shipping.
Is my price for teriflunomide 7 mg tablet fair?
Compare it with the fair cash price of $21.00 for 30 tablets. Up to about $26.25 is fair; above $42.00 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.
Is teriflunomide 7 mg tablet getting more expensive?
Over the last four weeks the price pharmacies pay rose 4.3%. Over a year it fell 43.8%. See the 52-week chart.
Who makes teriflunomide 7 mg tablet?
7 companies: Alembic Pharmaceuticals Inc., Aurobindo Pharma Limited, Biocon Pharma Inc., Camber Pharmaceuticals, Inc., Glenmark Pharmaceuticals Inc., USA, Teva Pharmaceuticals, Inc., Zydus Pharmaceuticals USA Inc.. See every package code.
Is teriflunomide in shortage?
No shortage is reported right now. We check every day.
Has teriflunomide been recalled?
1 recall on record, 1 ongoing. Recalls name specific lots - check yours.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about teriflunomide 7 mg tablet
No comments yet. Questions, tips, what worked for you - start the conversation.